Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | MACROH2A2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MACROH2A2 mRNA | CTD | PMID:22079256 | 1,3-dinitrobenzene | decreases expression | EXP | | 6480464 | 3-dinitrobenzene results in decreased expression of MACROH2A2 mRNA | CTD | PMID:21983209 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MACROH2A2 mRNA | CTD | PMID:26232522 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | Macroh2a2 (Mus musculus) | 6480464 | tetrabromobisphenol A results in decreased expression of MACROH2A2 mRNA | CTD | PMID:25172293 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of MACROH2A2 mRNA | CTD | PMID:24780913 | all-trans-retinoic acid | decreases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MACROH2A2 mRNA | CTD | PMID:33167477 | aristolochic acid A | decreases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of MACROH2A2 mRNA | CTD | PMID:33212167 | arsenous acid | decreases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of MACROH2A2 mRNA | CTD | PMID:22521957 | benzo[a]pyrene | affects methylation | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MACROH2A2 5' UTR | CTD | PMID:27901495 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MACROH2A2 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of MACROH2A2 protein | CTD | PMID:37567409 | bisphenol A | multiple interactions | ISO | MACROH2A2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of MACROH2A2 gene | CTD | PMID:31601247 | chlormequat chloride | increases expression | EXP | | 6480464 | Chlormequat results in increased expression of MACROH2A2 protein | CTD | PMID:34958886 | chromium(6+) | decreases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | chromium hexavalent ion results in decreased expression of MACROH2A2 mRNA | CTD | PMID:30690063 | copper atom | multiple interactions | ISO | MACROH2A2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of MACROH2A2 mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | MACROH2A2 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of MACROH2A2 mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of MACROH2A2 mRNA | CTD | PMID:19549813 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of MACROH2A2 mRNA | CTD | PMID:26577399 | cyclosporin A | decreases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of MACROH2A2 mRNA | CTD | PMID:25562108 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of MACROH2A2 mRNA | CTD | PMID:23914054 | diarsenic trioxide | decreases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of MACROH2A2 mRNA | CTD | PMID:22521957 | dorsomorphin | multiple interactions | ISO | MACROH2A2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MACROH2A2 mRNA | CTD | PMID:27188386 | doxorubicin | affects expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Doxorubicin affects the expression of MACROH2A2 mRNA | CTD | PMID:29803840 | elemental selenium | increases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Selenium results in increased expression of MACROH2A2 mRNA | CTD | PMID:19244175 | entinostat | decreases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | entinostat results in decreased expression of MACROH2A2 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | MACROH2A2 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MACROH2A2 mRNA | CTD | PMID:27188386 | folic acid | increases expression | ISO | Macroh2a2 (Mus musculus) | 6480464 | Folic Acid results in increased expression of MACROH2A2 mRNA | CTD | PMID:25629700 | fonofos | increases methylation | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Fonofos results in increased methylation of MACROH2A2 promoter | CTD | PMID:22847954 | fulvestrant | multiple interactions | ISO | MACROH2A2 (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of MACROH2A2 gene | CTD | PMID:31601247 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of MACROH2A2 mRNA | CTD | PMID:33387578 | ivermectin | increases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Ivermectin results in increased expression of MACROH2A2 protein | CTD | PMID:32959892 | paracetamol | affects expression | ISO | Macroh2a2 (Mus musculus) | 6480464 | Acetaminophen affects the expression of MACROH2A2 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of MACROH2A2 mRNA | CTD | PMID:33387578 | paracetamol | decreases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of MACROH2A2 mRNA | CTD | PMID:29067470 | parathion | increases methylation | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Parathion results in increased methylation of MACROH2A2 promoter | CTD | PMID:22847954 | potassium chromate | multiple interactions | ISO | MACROH2A2 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MACROH2A2 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of MACROH2A2 mRNA | CTD | PMID:22079256 and PMID:22714537 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | Macroh2a2 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in increased expression of MACROH2A2 mRNA | CTD | PMID:22698814 | propionic acid | decreases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | propionic acid results in decreased expression of MACROH2A2 mRNA | CTD | PMID:31526819 | SB 431542 | multiple interactions | ISO | MACROH2A2 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 | selenium atom | increases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Selenium results in increased expression of MACROH2A2 mRNA | CTD | PMID:19244175 | sodium arsenite | decreases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of MACROH2A2 mRNA | CTD | PMID:22714537 | sodium arsenite | increases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of MACROH2A2 mRNA | CTD | PMID:29301061 | sodium fluoride | decreases expression | ISO | Macroh2a2 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of MACROH2A2 protein | CTD | PMID:28918527 | terbufos | increases methylation | ISO | MACROH2A2 (Homo sapiens) | 6480464 | terbufos results in increased methylation of MACROH2A2 promoter | CTD | PMID:22847954 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of MACROH2A2 mRNA | CTD | PMID:34492290 | triptonide | decreases expression | ISO | Macroh2a2 (Mus musculus) | 6480464 | triptonide results in decreased expression of MACROH2A2 mRNA | CTD | PMID:33045310 | urethane | decreases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Urethane results in decreased expression of MACROH2A2 mRNA | CTD | PMID:28818685 | valproic acid | decreases methylation | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of MACROH2A2 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of MACROH2A2 mRNA | CTD | PMID:23179753 more ... | valproic acid | affects expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MACROH2A2 mRNA | CTD | PMID:25979313 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of MACROH2A2 mRNA | CTD | PMID:22570695 | vitamin E | increases expression | ISO | MACROH2A2 (Homo sapiens) | 6480464 | Vitamin E results in increased expression of MACROH2A2 mRNA | CTD | PMID:19244175 | |